When Stress Accumulates, the Body Needs a Smarter Protocol
High-stress periods do not just wear on the mind — they disrupt metabolism, elevate cortisol, blunt recovery, and make it significantly harder to manage body composition. Appetite becomes erratic, energy expenditure drops, and fat storage — particularly around the midsection — tends to accelerate. Standard approaches often fall short precisely when the pressure is highest.
This is the environment that ShredMAX 20mg was designed for. By pairing two distinct and complementary peptides in a single ready-to-use pen, it addresses fat loss from two separate biological angles simultaneously — metabolic regulation and targeted lipolysis — without requiring reconstitution, mixing, or complex scheduling.
What ShredMAX 20mg Actually Contains
ShredMAX 20mg is a combined formula housing Retatrutide 10mg and AOD-9604 10mg in a 1:1 ratio, totalling 20mg per pen. It is supplied in the OlympusPen format — 110 clicks per pen — and requires no preparation before use. Each click delivers approximately 0.091mg of Retatrutide and 0.091mg of AOD-9604.
The recommended weekly dose is approximately 55 clicks, delivering 5mg of each peptide. For those beginning a new protocol or titrating conservatively, the starting dose is approximately 28 clicks per week — roughly 2.5mg of each component. The simplicity of this delivery format is deliberate: one pen, one protocol, two mechanisms working in parallel.
Retatrutide: The Triple Receptor Mechanism
Retatrutide is among the most advanced metabolic peptides currently available in research. It functions as a triple agonist of the GLP-1, GIP, and glucagon receptors — three distinct pathways that together influence appetite signalling, energy expenditure, and the way the body allocates and burns fuel.
Where single-receptor GLP-1 agonists address satiety alone, Retatrutide's triple mechanism adds the metabolic amplification of glucagon receptor activity and the insulin-sensitising dimension of GIP. In practical terms, this means the molecule works not only on how much you eat, but on how efficiently your body uses the energy it receives — a meaningful distinction during stress-heavy periods when metabolic efficiency tends to decline.
AOD-9604: Targeted Lipolysis Without Metabolic Disruption
AOD-9604 is a modified fragment of human growth hormone, engineered specifically to isolate and replicate its lipolytic properties — the breakdown of stored fat — while leaving anabolic signalling and blood glucose regulation untouched. It does not affect IGF-1 levels, which makes it a precise tool rather than a broad hormonal intervention.
In the context of ShredMAX, AOD-9604 complements Retatrutide's systemic metabolic work with a more targeted action on fat cell mobilisation. While Retatrutide manages appetite and energy dynamics from the top down, AOD-9604 operates at the level of fat depots directly — encouraging the body to break down and utilise stored fat as fuel.
Why the Combination Matters During High-Stress Periods
Chronic stress creates a physiological environment that is actively resistant to fat loss. Elevated cortisol promotes fat retention, disrupts sleep — which in turn compromises appetite hormones — and reduces the body's natural inclination to use stored fat for energy. A single-mechanism approach rarely addresses this complexity adequately.
ShredMAX 20mg is structured to work across multiple points of this resistance simultaneously:
- Appetite and satiety regulation — via Retatrutide's GLP-1 and GIP receptor activity, helping to normalise hunger signals that stress distorts
- Energy expenditure support — through Retatrutide's glucagon receptor engagement, encouraging the body to burn rather than conserve
- Direct lipolysis — via AOD-9604's action on fat cell breakdown, accelerating the mobilisation of stored fat
- Metabolic precision — AOD-9604 does not interfere with blood sugar or IGF-1, keeping the protocol clean and focused
- Protocol simplicity — no reconstitution, no separate pens, no complex timing windows
- Titration flexibility — a conservative starting dose allows gradual adaptation before moving to the full weekly protocol
For individuals managing demanding work schedules, athletic training loads, or simply sustained periods of elevated stress, this kind of layered support can make a measurable difference to body composition outcomes.
ShredMAX 20mg in Practice: Dosing and Format
The OlympusPen format removes one of the most common barriers to peptide compliance — preparation complexity. There is no mixing, no water for injection, no vial management. The pen is ready to use from the moment it arrives, which matters considerably when schedule pressure is already high.
A sensible approach begins at approximately 28 clicks per week (2.5mg Retatrutide + 2.5mg AOD-9604), allowing the body to adapt to both peptides before advancing to the full recommended dose of 55 clicks per week (5mg + 5mg). One pen contains 110 clicks — enough for two full weeks at the recommended dose, or longer during a titration phase.
Those looking to run an extended protocol or maintain consistent supply without interruption can explore volume options through the Olympus Meds bulk page, where multi-unit arrangements are available.
Supporting Recovery Alongside Fat Loss
Body composition work during high-stress periods is rarely just about fat loss in isolation. Physical recovery, tissue integrity, and systemic resilience all play a role in whether a protocol sustains itself over weeks or begins to erode under accumulated load. For those running ShredMAX alongside an active training schedule, pairing it with a dedicated recovery peptide can help maintain structural balance.
BPC-157 + TB-500 is a well-regarded synergistic recovery formula that addresses soft tissue regeneration and systemic cellular repair — complementing the metabolic focus of ShredMAX without overlap. The two protocols operate in entirely separate physiological lanes, making them logistically compatible for individuals managing a broader wellness strategy.
You can also review current product availability and stock status directly on the Olympus Meds status page before placing an order.
Where to Start with ShredMAX 20mg
If you are entering a period that demands stronger recovery habits and more deliberate body composition support, ShredMAX 20mg offers a structured, dual-mechanism starting point. Its combination of Retatrutide's metabolic breadth and AOD-9604's targeted lipolytic action makes it one of the more complete fat-loss formulas currently available in a single-pen format.
For single-unit orders, visit the ShredMAX 20mg product page. For those planning a longer protocol or looking to reduce per-unit cost, the Olympus Meds bulk page is the right place to start. Olympus Meds supplies research-grade peptides in ready-to-use OlympusPen format — precision, quality, and protocol simplicity in every order.
Frequently Asked Questions
Can ShredMAX 20mg be used during a caloric deficit?
ShredMAX is designed to support body composition, and its components — particularly Retatrutide's appetite-regulating properties — may make it easier to maintain a moderate caloric deficit without the intensity of hunger that often disrupts such protocols. AOD-9604's lipolytic action is relevant regardless of caloric context, though it works within the body's broader metabolic environment.
How long does one ShredMAX 20mg pen last?
Each pen contains 110 clicks. At the recommended weekly dose of 55 clicks, one pen provides approximately two weeks of use. At the starting titration dose of 28 clicks per week, the pen extends to roughly four weeks. Exact duration depends on the dose selected and individual protocol design.
Is ShredMAX 20mg suitable as a first peptide protocol?
ShredMAX is formulated with a conservative titration dose that allows new users to begin gradually. The no-reconstitution OlympusPen format also removes preparation complexity that can be a barrier for first-time users. As with any peptide protocol, it is advisable to begin at the lower titration dose and assess individual response before advancing to the full weekly recommendation.